Can serum catecholamine at 1 week after I-131 MIBG therapy predict response in malignant pheochromocytoma?

被引：0
|
作者：
Higuchi, T. [1 ]
Oriuchi, N. [1 ]
Arisaka, Y. [1 ]
Miyashita, G. [2 ]
Ishikia, T. [2 ]
Hanaoka, H. [3 ]
Otake, H. [4 ]
Koyama, K. [5 ]
Endo, K. [1 ]
机构：
[1] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma 371, Japan
[2] Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, Maebashi, Gunma 371, Japan
[3] Gunma Univ, Grad Sch Med, Dept Bioimaging Informat Anal, Maebashi, Gunma 371, Japan
[4] Gunma Univ Hosp, Dept Radiol, Maebashi, Gunma, Japan
[5] Gunma Prefectural Cardiovasc Ctr, Dept Radiol, Maebashi, Gunma, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S418 / S418
页数：1
相关论文
共 50 条
  • [21] Short Term Response to Systemic I-131 MIBG Therapy in Metastatic Carcinoid Tumors
    Campeau, Richard J.
    Anthony, Lowell B.
    Woltering, Eugene A.
    Wang, Yi-Zarn
    Boudreaux, J. Phillip
    PANCREAS, 2011, 40 (02) : 325 - 325
  • [22] THYROGLOBULIN IN SERUM AFTER I-131 THERAPY .1. SALTING OUT
    ROBBINS, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1954, 208 (01) : 377 - 386
  • [23] Brown adipose tissue; a factor to consider in symmetrical FDG uptake shown in the shoulder, neck and thoracic spine region after I-131 MIBG therapy to malignant pheochromocytoma
    Higuchi, T
    Oriuchi, N
    Miyakubo, M
    Arai, K
    Koyama, Y
    Tian, M
    Khan, N
    Otake, H
    Endo, K
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S341 - S341
  • [24] 131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumours - a single-centre study
    Kotecka-Blicharz, Agnieszka
    Hasse-Lazar, Kornelia
    Handkiewicz-Junak, Daria
    Gawlik, Tomasz
    Pawlaczek, Agnieszka
    Oczko-Wojciechowska, Malgorzata
    Michalik, Barbara
    Szpak-Ulczok, Sylwia
    Krajewska, Jolanta
    Jurecka-Lubieniecka, Beata
    Jarzab, Barbara
    ENDOKRYNOLOGIA POLSKA, 2018, 69 (03) : 246 - 251
  • [25] Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma
    Noto, Richard B.
    Pryma, Daniel A.
    Jensen, Jessica
    Lin, Tess
    Stambler, Nancy
    Strack, Thomas
    Wong, Vivien
    Goldsmith, Stanley J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (01): : 213 - 220
  • [26] Iodine-131 metaiodobenzylguanidine (I-131 MIBG) diagnosis and therapy of pheochromocytoma and paraganglioma: current problems, critical issues and presentation of a sample case
    Castellani, M. R.
    Aktolun, C.
    Buzzoni, R.
    Seregni, E.
    Chiesa, C.
    Maccauro, M.
    Aliberti, G. L.
    Vellani, C.
    Lorenzoni, A.
    Bombardieri, E.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 57 (02): : 146 - 152
  • [27] Adverse Prognostic Factors in Patients Refractory Pheochromocytoma and Paraganglioma After 131I-metaiodinebenzylguanidine (131I-mIBG) Therapy
    Hiromasa, T.
    Wakabayashi, H.
    Kayano, D.
    Inaki, A.
    Toratani, A.
    Akatani, N.
    Watanabe, S.
    Yamase, T.
    Kunita, Y.
    Mori, H.
    Saito, S.
    Takata, A.
    Kinuya, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S568 - S569
  • [28] External Beam Radiation Therapy With or Without 131I-MIBG Systemic Radiation Therapy in the Therapy Of Patients With Malignant Pheochromocytoma and Paraganglioma
    Cengel, K. A.
    Lauren, F.
    Alonso-Basanta, M.
    Pryma, D.
    Simone, C. B.
    Findlay, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S615 - S616
  • [29] THYROGLOBULIN IN SERUM AFTER I-131 THERAPY .2. SEDIMENTATION IN THE ULTRACENTRIFUGE
    ROBBINS, J
    PETERMANN, ML
    RALL, JE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1954, 208 (01) : 387 - 393
  • [30] MALIGNANT THYROID-TUMORS AFTER I-131 THERAPY - A RETROSPECTIVE COHORT STUDY
    HOLM, LE
    DAHLQVIST, I
    ISRAELSSON, A
    LUNDELL, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (04): : 188 - 191
12345